342 related articles for article (PubMed ID: 16289997)
1. Regulation of immunologicals in the European union: current and emerging issues.
Kriz NG;
Biologicals; 2005 Dec; 33(4):247-52. PubMed ID: 16289997
[No Abstract] [Full Text] [Related]
2. Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination.
Bergmann IE; Malirat V; Neitzert E
Biologicals; 2005 Dec; 33(4):235-9. PubMed ID: 16257539
[TBL] [Abstract][Full Text] [Related]
3. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
Brehm KE; Kumar N; Thulke HH; Haas B
Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
[TBL] [Abstract][Full Text] [Related]
4. [Vaccination against foot and mouth disease: current state and perspectives].
Visser N; Thiel HJ
Dtsch Tierarztl Wochenschr; 2001 Dec; 108(12):522-5. PubMed ID: 11822168
[TBL] [Abstract][Full Text] [Related]
5. [A review of the risks involved in the import of foot and mouth disease vaccinated animals and the products of such animals].
Sutmoller P
Tijdschr Diergeneeskd; 2004 Jun; 129(12):408-9. PubMed ID: 15232965
[No Abstract] [Full Text] [Related]
6. [The effectiveness of vaccination to prevent foot and mouth disease in several species].
Orsel K
Tijdschr Diergeneeskd; 2008 Jan; 133(1):14-6. PubMed ID: 18260556
[No Abstract] [Full Text] [Related]
7. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
Fowler VL; Paton DJ; Rieder E; Barnett PV
Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
[TBL] [Abstract][Full Text] [Related]
8. Authorisation within the European Union of vaccines against antigenically variable viruses responsible for major epizootic diseases.
Mackay DK
Rev Sci Tech; 2007 Aug; 26(2):421-8. PubMed ID: 17892162
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against foot-and-mouth disease: the implications for Canada.
Kahn S; Geale DW; Kitching PR; Bouffard A; Allard DG; Duncan JR
Can Vet J; 2002 May; 43(5):349-54. PubMed ID: 12001500
[TBL] [Abstract][Full Text] [Related]
10. Making a vaccinate-to-live policy a reality in foot-and-mouth disease.
Mackay D; Parida S; Paton D; Anderson J
Dev Biol (Basel); 2004; 119():261-6. PubMed ID: 15742637
[TBL] [Abstract][Full Text] [Related]
11. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
Lombard M; Füssel AE
Rev Sci Tech; 2007 Apr; 26(1):117-34. PubMed ID: 17633297
[TBL] [Abstract][Full Text] [Related]
12. Foot and Mouth's Achilles' heel?
Atkins JF; Ryan MD
Nat Biotechnol; 2008 Dec; 26(12):1335-6. PubMed ID: 19060865
[No Abstract] [Full Text] [Related]
13. Proper quality control of formulated foot-and-mouth disease vaccines in countries with prophylactic vaccination is necessary.
Jamal SM; Shah SI; Ali Q; Mehmood A; Afzal M; Afzal M; Dekker A
Transbound Emerg Dis; 2014 Dec; 61(6):483-9. PubMed ID: 23305464
[TBL] [Abstract][Full Text] [Related]
14. [Value of specific prevention of foot-and-mouth disease].
Antoniuk VP; Kruglikov BA; Barbashov VP; Bashkatov SF; Makarevich FG
Veterinariia; 1971 Aug; 9():46-8. PubMed ID: 5140676
[No Abstract] [Full Text] [Related]
15. [Vaccination against foot and mouth disease: a biotechnical approach?].
Moormann RJ
Tijdschr Diergeneeskd; 2001 Dec; 126(24):785-7. PubMed ID: 11780258
[TBL] [Abstract][Full Text] [Related]
16. [Foot and mouth disease legislation: we are still not there!].
Sutmoller P
Tijdschr Diergeneeskd; 2004 Feb; 129(4):123-4. PubMed ID: 15002210
[No Abstract] [Full Text] [Related]
17. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
[TBL] [Abstract][Full Text] [Related]
18. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
Niedbalski W
Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
[TBL] [Abstract][Full Text] [Related]
19. Presence of antibodies to non-structural proteins of foot-and-mouth disease virus in repeatedly vaccinated cattle.
Lee F; Jong MH; Yang DW
Vet Microbiol; 2006 Jun; 115(1-3):14-20. PubMed ID: 16446061
[TBL] [Abstract][Full Text] [Related]
20. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
Yao Q; Qian P; Huang Q; Cao Y; Chen H
J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
